| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 98 | 2023 | 900 | 17.070 |
Why?
|
| Islets of Langerhans | 70 | 2023 | 1349 | 8.300 |
Why?
|
| Receptor, Insulin | 45 | 2022 | 838 | 5.600 |
Why?
|
| Insulin | 113 | 2023 | 6606 | 5.010 |
Why?
|
| Insulin Resistance | 48 | 2025 | 3974 | 4.050 |
Why?
|
| Glucagon-Secreting Cells | 12 | 2023 | 42 | 3.980 |
Why?
|
| Pancreas | 24 | 2024 | 1703 | 2.850 |
Why?
|
| Diabetes Mellitus, Type 2 | 52 | 2023 | 12242 | 2.540 |
Why?
|
| Glucagon | 13 | 2023 | 534 | 2.480 |
Why?
|
| Insulin Receptor Substrate Proteins | 23 | 2021 | 558 | 2.090 |
Why?
|
| Mice, Knockout | 79 | 2025 | 14480 | 2.010 |
Why?
|
| Adenosine | 3 | 2025 | 816 | 2.000 |
Why?
|
| Glucose | 59 | 2024 | 4355 | 1.990 |
Why?
|
| Cell Proliferation | 39 | 2024 | 10494 | 1.980 |
Why?
|
| Induced Pluripotent Stem Cells | 10 | 2021 | 1890 | 1.890 |
Why?
|
| Pancreatic Ducts | 4 | 2024 | 330 | 1.850 |
Why?
|
| Pancreas, Exocrine | 7 | 2023 | 48 | 1.820 |
Why?
|
| Signal Transduction | 66 | 2024 | 23638 | 1.770 |
Why?
|
| Methyltransferases | 3 | 2025 | 375 | 1.740 |
Why?
|
| Glucagon-Like Peptide 1 | 13 | 2022 | 367 | 1.690 |
Why?
|
| Receptor, IGF Type 1 | 14 | 2023 | 384 | 1.540 |
Why?
|
| Mice | 148 | 2025 | 82045 | 1.450 |
Why?
|
| Diabetes Mellitus, Experimental | 13 | 2022 | 1121 | 1.410 |
Why?
|
| Receptors, Leptin | 7 | 2020 | 351 | 1.390 |
Why?
|
| Animals | 185 | 2025 | 169418 | 1.330 |
Why?
|
| Cell Differentiation | 14 | 2024 | 11674 | 1.220 |
Why?
|
| Diabetes Mellitus, Type 1 | 11 | 2021 | 3440 | 1.200 |
Why?
|
| Glucose Intolerance | 9 | 2021 | 579 | 1.160 |
Why?
|
| RNA, Messenger | 15 | 2025 | 12813 | 1.130 |
Why?
|
| STAT3 Transcription Factor | 5 | 2021 | 873 | 1.080 |
Why?
|
| Apoptosis | 18 | 2025 | 9526 | 1.030 |
Why?
|
| Phosphoproteins | 20 | 2019 | 2450 | 1.030 |
Why?
|
| Adipose Tissue, Brown | 7 | 2025 | 776 | 1.000 |
Why?
|
| Gene Expression Regulation | 21 | 2021 | 11930 | 0.940 |
Why?
|
| Pluripotent Stem Cells | 3 | 2021 | 808 | 0.940 |
Why?
|
| Hyperglycemia | 15 | 2019 | 1389 | 0.920 |
Why?
|
| Adipocytes, White | 1 | 2025 | 92 | 0.910 |
Why?
|
| Blood Glucose | 28 | 2022 | 6429 | 0.900 |
Why?
|
| Hyperinsulinism | 10 | 2017 | 401 | 0.890 |
Why?
|
| Carboxylesterase | 2 | 2013 | 31 | 0.880 |
Why?
|
| Adipocytes | 7 | 2024 | 1199 | 0.860 |
Why?
|
| Coagulants | 3 | 2018 | 45 | 0.840 |
Why?
|
| Hypoglycemia | 4 | 2023 | 894 | 0.820 |
Why?
|
| Mice, Inbred C57BL | 53 | 2025 | 22365 | 0.790 |
Why?
|
| Diabetes Mellitus | 17 | 2023 | 5887 | 0.790 |
Why?
|
| Cell Cycle Proteins | 10 | 2017 | 3463 | 0.790 |
Why?
|
| Protein Biosynthesis | 6 | 2020 | 2096 | 0.760 |
Why?
|
| Proteome | 5 | 2020 | 1881 | 0.740 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3826 | 0.730 |
Why?
|
| Proteomics | 9 | 2021 | 3901 | 0.730 |
Why?
|
| Serpins | 3 | 2018 | 247 | 0.710 |
Why?
|
| Cell Communication | 5 | 2023 | 1662 | 0.690 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2020 | 112 | 0.680 |
Why?
|
| Molecular Probes | 2 | 2021 | 310 | 0.670 |
Why?
|
| Islets of Langerhans Transplantation | 10 | 2022 | 748 | 0.660 |
Why?
|
| MAP Kinase Signaling System | 4 | 2019 | 1489 | 0.630 |
Why?
|
| Hemophilia A | 5 | 2016 | 359 | 0.620 |
Why?
|
| Factor X Deficiency | 1 | 2018 | 8 | 0.620 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2020 | 1170 | 0.620 |
Why?
|
| Hepatocytes | 4 | 2023 | 1247 | 0.610 |
Why?
|
| Glucokinase | 7 | 2018 | 102 | 0.610 |
Why?
|
| Factor X | 1 | 2018 | 64 | 0.610 |
Why?
|
| Lipid Metabolism | 6 | 2023 | 1898 | 0.590 |
Why?
|
| Liver | 21 | 2024 | 7575 | 0.580 |
Why?
|
| Homeostasis | 13 | 2020 | 3351 | 0.580 |
Why?
|
| Methylation | 5 | 2024 | 1077 | 0.570 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2016 | 93 | 0.570 |
Why?
|
| Adipose Tissue, White | 7 | 2025 | 371 | 0.550 |
Why?
|
| Hypoglycemic Agents | 11 | 2017 | 3111 | 0.550 |
Why?
|
| Gastric Inhibitory Polypeptide | 3 | 2022 | 69 | 0.540 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 154 | 0.530 |
Why?
|
| Mice, Inbred NOD | 8 | 2022 | 1839 | 0.520 |
Why?
|
| Humans | 153 | 2025 | 768451 | 0.520 |
Why?
|
| Incretins | 3 | 2022 | 100 | 0.510 |
Why?
|
| Embryonic Development | 1 | 2021 | 722 | 0.510 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 208 | 0.500 |
Why?
|
| Cells, Cultured | 24 | 2021 | 19041 | 0.500 |
Why?
|
| Molecular Imaging | 2 | 2021 | 825 | 0.500 |
Why?
|
| von Willebrand Diseases | 1 | 2017 | 134 | 0.500 |
Why?
|
| Hyperplasia | 7 | 2016 | 1154 | 0.500 |
Why?
|
| Transcription Factors | 13 | 2022 | 12174 | 0.490 |
Why?
|
| Endocrine System | 1 | 2016 | 113 | 0.490 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2016 | 176 | 0.490 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2020 | 2538 | 0.480 |
Why?
|
| Pancreatic Diseases | 3 | 2023 | 353 | 0.480 |
Why?
|
| Phosphorylation | 13 | 2021 | 8332 | 0.480 |
Why?
|
| Carboxypeptidase H | 1 | 2014 | 9 | 0.470 |
Why?
|
| RNA | 3 | 2021 | 2727 | 0.470 |
Why?
|
| Models, Biological | 15 | 2016 | 9505 | 0.460 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2020 | 1660 | 0.460 |
Why?
|
| Fibroblasts | 4 | 2021 | 4180 | 0.460 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1143 | 0.460 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2014 | 68 | 0.450 |
Why?
|
| Regeneration | 5 | 2017 | 1527 | 0.440 |
Why?
|
| Immune System | 1 | 2019 | 801 | 0.440 |
Why?
|
| Secretin | 1 | 2013 | 57 | 0.440 |
Why?
|
| Menorrhagia | 2 | 2017 | 59 | 0.440 |
Why?
|
| Endoderm | 1 | 2014 | 165 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2016 | 2465 | 0.420 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 717 | 0.420 |
Why?
|
| Activins | 1 | 2014 | 211 | 0.410 |
Why?
|
| Autoantigens | 1 | 2017 | 894 | 0.410 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2012 | 44 | 0.410 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2017 | 776 | 0.400 |
Why?
|
| Amino Acids | 2 | 2023 | 1714 | 0.400 |
Why?
|
| Lipolysis | 2 | 2013 | 211 | 0.400 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2012 | 57 | 0.400 |
Why?
|
| Leptin | 16 | 2017 | 1598 | 0.400 |
Why?
|
| Blood Coagulation | 1 | 2018 | 1162 | 0.390 |
Why?
|
| Exocytosis | 3 | 2010 | 323 | 0.390 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 733 | 0.380 |
Why?
|
| Cyclin D2 | 2 | 2019 | 98 | 0.380 |
Why?
|
| Obesity | 18 | 2024 | 13065 | 0.380 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 2006 | 1943 | 0.380 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 848 | 0.370 |
Why?
|
| Lipase | 3 | 2022 | 321 | 0.370 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 329 | 0.360 |
Why?
|
| Thermogenesis | 3 | 2024 | 494 | 0.360 |
Why?
|
| Male | 97 | 2025 | 364781 | 0.360 |
Why?
|
| Calcium | 8 | 2016 | 5793 | 0.350 |
Why?
|
| PPAR gamma | 2 | 2015 | 487 | 0.350 |
Why?
|
| Health Education | 1 | 2017 | 1059 | 0.350 |
Why?
|
| Venoms | 4 | 2017 | 94 | 0.350 |
Why?
|
| Sulfonylurea Compounds | 1 | 2012 | 220 | 0.350 |
Why?
|
| Phenotype | 11 | 2020 | 16712 | 0.350 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2010 | 86 | 0.340 |
Why?
|
| Energy Metabolism | 11 | 2024 | 2901 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 3 | 2021 | 4417 | 0.340 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 14 | 2015 | 4586 | 0.340 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2531 | 0.340 |
Why?
|
| Thiazolidinediones | 2 | 2012 | 462 | 0.330 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9507 | 0.330 |
Why?
|
| Pancreatic Cyst | 1 | 2013 | 369 | 0.330 |
Why?
|
| Deoxycytidine | 5 | 2014 | 888 | 0.330 |
Why?
|
| Receptor, Cannabinoid, CB1 | 3 | 2018 | 137 | 0.320 |
Why?
|
| Cell Adhesion Molecules | 4 | 2017 | 1615 | 0.310 |
Why?
|
| Gastric Bypass | 1 | 2017 | 829 | 0.310 |
Why?
|
| Hemorrhage | 2 | 2018 | 3458 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2017 | 4534 | 0.310 |
Why?
|
| Dietary Fats | 6 | 2016 | 2003 | 0.300 |
Why?
|
| Growth Substances | 2 | 2008 | 761 | 0.300 |
Why?
|
| Hypothalamic Hormones | 2 | 2007 | 145 | 0.300 |
Why?
|
| Pituitary Hormones | 2 | 2007 | 182 | 0.300 |
Why?
|
| Cell Line | 20 | 2021 | 15609 | 0.300 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2243 | 0.290 |
Why?
|
| Lymphocytes | 1 | 2016 | 2611 | 0.290 |
Why?
|
| Pregnancy | 8 | 2023 | 30179 | 0.290 |
Why?
|
| Ephrins | 1 | 2007 | 28 | 0.280 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1409 | 0.280 |
Why?
|
| Receptors, Eph Family | 1 | 2007 | 45 | 0.280 |
Why?
|
| Trans-Activators | 6 | 2014 | 2858 | 0.280 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 2007 | 29 | 0.280 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1892 | 0.280 |
Why?
|
| Protein Isoforms | 2 | 2013 | 1706 | 0.280 |
Why?
|
| Adipocytes, Brown | 2 | 2025 | 160 | 0.280 |
Why?
|
| Insulinoma | 5 | 2000 | 122 | 0.280 |
Why?
|
| Melanins | 2 | 2007 | 290 | 0.280 |
Why?
|
| Mice, Obese | 7 | 2022 | 418 | 0.270 |
Why?
|
| Homeodomain Proteins | 5 | 2022 | 2430 | 0.270 |
Why?
|
| Disease Models, Animal | 13 | 2019 | 18388 | 0.270 |
Why?
|
| Mice, Mutant Strains | 8 | 2017 | 1755 | 0.270 |
Why?
|
| Prediabetic State | 1 | 2012 | 548 | 0.270 |
Why?
|
| Blotting, Western | 8 | 2015 | 5042 | 0.260 |
Why?
|
| Pancreatic Elastase | 2 | 2023 | 126 | 0.260 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 1669 | 0.260 |
Why?
|
| Neurons | 3 | 2021 | 9504 | 0.260 |
Why?
|
| Fluorescent Dyes | 4 | 2021 | 1924 | 0.250 |
Why?
|
| DNA Damage | 1 | 2015 | 2461 | 0.250 |
Why?
|
| Calcium Signaling | 3 | 2012 | 737 | 0.250 |
Why?
|
| Repressor Proteins | 3 | 2020 | 2987 | 0.250 |
Why?
|
| Cytokines | 3 | 2016 | 7449 | 0.240 |
Why?
|
| Sumoylation | 2 | 2017 | 83 | 0.240 |
Why?
|
| MicroRNAs | 3 | 2021 | 3805 | 0.240 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2018 | 1254 | 0.240 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2019 | 1197 | 0.230 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 1259 | 0.230 |
Why?
|
| Factor VIII | 3 | 2016 | 349 | 0.230 |
Why?
|
| Wnt Proteins | 1 | 2008 | 724 | 0.230 |
Why?
|
| Telomerase | 1 | 2009 | 751 | 0.230 |
Why?
|
| Ion Channels | 1 | 2009 | 1044 | 0.230 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 122 | 0.230 |
Why?
|
| Glucose Tolerance Test | 11 | 2020 | 1181 | 0.230 |
Why?
|
| Female | 56 | 2023 | 396943 | 0.220 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2024 | 169 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2025 | 257 | 0.220 |
Why?
|
| Cell Nucleus | 3 | 2017 | 2889 | 0.220 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2025 | 195 | 0.220 |
Why?
|
| C-Peptide | 5 | 2022 | 444 | 0.220 |
Why?
|
| Intracranial Hemorrhages | 1 | 2009 | 815 | 0.220 |
Why?
|
| Prostaglandins | 1 | 2024 | 398 | 0.220 |
Why?
|
| RNA Stability | 2 | 2025 | 322 | 0.220 |
Why?
|
| Fluoresceins | 1 | 2023 | 236 | 0.220 |
Why?
|
| Stem Cells | 1 | 2016 | 3538 | 0.220 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 979 | 0.220 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2017 | 432 | 0.220 |
Why?
|
| Telomere | 1 | 2009 | 943 | 0.210 |
Why?
|
| Mice, Transgenic | 16 | 2024 | 9558 | 0.210 |
Why?
|
| Arginine | 2 | 2022 | 923 | 0.210 |
Why?
|
| Proteostasis Deficiencies | 2 | 2013 | 39 | 0.210 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 2015 | 285 | 0.210 |
Why?
|
| Lipids | 2 | 2021 | 3346 | 0.210 |
Why?
|
| E2F1 Transcription Factor | 1 | 2022 | 182 | 0.200 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2014 | 414 | 0.200 |
Why?
|
| Neuropeptide Y | 2 | 2000 | 194 | 0.200 |
Why?
|
| Peptides | 5 | 2017 | 4368 | 0.200 |
Why?
|
| Lactams | 2 | 2013 | 158 | 0.200 |
Why?
|
| Delivery, Obstetric | 1 | 2009 | 953 | 0.200 |
Why?
|
| Antiviral Agents | 5 | 2019 | 3063 | 0.200 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2014 | 77 | 0.200 |
Why?
|
| Gene Knockout Techniques | 4 | 2020 | 808 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2021 | 474 | 0.190 |
Why?
|
| Muscle, Skeletal | 8 | 2017 | 4984 | 0.190 |
Why?
|
| Ribavirin | 2 | 2013 | 395 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2021 | 478 | 0.190 |
Why?
|
| Dinoprostone | 1 | 2024 | 597 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2021 | 2477 | 0.190 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2024 | 515 | 0.190 |
Why?
|
| Organ Size | 4 | 2019 | 2268 | 0.180 |
Why?
|
| Cell Survival | 5 | 2017 | 5801 | 0.180 |
Why?
|
| Streptozocin | 3 | 2011 | 195 | 0.180 |
Why?
|
| Mutant Proteins | 2 | 2013 | 489 | 0.180 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 286 | 0.180 |
Why?
|
| Pyruvate Kinase | 1 | 2022 | 190 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 4419 | 0.180 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 9623 | 0.180 |
Why?
|
| Mitochondria | 5 | 2024 | 3672 | 0.180 |
Why?
|
| Interleukin-18 | 1 | 2022 | 251 | 0.180 |
Why?
|
| Hepatitis C, Chronic | 3 | 2013 | 1031 | 0.180 |
Why?
|
| Gene Targeting | 2 | 2007 | 842 | 0.180 |
Why?
|
| Cell Lineage | 2 | 2020 | 2575 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 2969 | 0.180 |
Why?
|
| MafG Transcription Factor | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hepacivirus | 5 | 2014 | 1342 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2964 | 0.170 |
Why?
|
| Cell Division | 5 | 2015 | 4479 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2018 | 3408 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1608 | 0.170 |
Why?
|
| Sorbitol | 1 | 2020 | 60 | 0.170 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2021 | 221 | 0.170 |
Why?
|
| Solubility | 1 | 2022 | 1086 | 0.170 |
Why?
|
| Gene Expression | 8 | 2015 | 7605 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2013 | 4642 | 0.170 |
Why?
|
| 3T3-L1 Cells | 4 | 2015 | 208 | 0.170 |
Why?
|
| Carbon | 1 | 2023 | 671 | 0.170 |
Why?
|
| Glyburide | 1 | 2000 | 117 | 0.170 |
Why?
|
| Membrane Proteins | 3 | 2022 | 7895 | 0.160 |
Why?
|
| Anemia, Megaloblastic | 1 | 2019 | 24 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2022 | 2633 | 0.160 |
Why?
|
| Flow Cytometry | 4 | 2021 | 5904 | 0.160 |
Why?
|
| Interferon-alpha | 2 | 2013 | 909 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5367 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2008 | 2030 | 0.160 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2018 | 22 | 0.160 |
Why?
|
| Chromatography, Liquid | 2 | 2015 | 998 | 0.160 |
Why?
|
| Culture Media, Conditioned | 3 | 2020 | 522 | 0.160 |
Why?
|
| Antigens, CD | 4 | 2018 | 4029 | 0.160 |
Why?
|
| Neurotransmitter Agents | 2 | 2010 | 666 | 0.160 |
Why?
|
| Adult | 32 | 2022 | 223542 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 124 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2019 | 586 | 0.150 |
Why?
|
| Gonadal Hormones | 1 | 2018 | 30 | 0.150 |
Why?
|
| Protein Kinase C-delta | 1 | 2018 | 115 | 0.150 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2020 | 199 | 0.150 |
Why?
|
| Cell Transdifferentiation | 1 | 2019 | 188 | 0.150 |
Why?
|
| Molecular Structure | 2 | 2021 | 1889 | 0.150 |
Why?
|
| Oxygen Consumption | 5 | 2016 | 1882 | 0.150 |
Why?
|
| Viral Nonstructural Proteins | 3 | 2014 | 229 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 2 | 2014 | 1129 | 0.150 |
Why?
|
| Phosphopeptides | 1 | 2019 | 240 | 0.150 |
Why?
|
| Polyethylene Glycols | 2 | 2013 | 1195 | 0.150 |
Why?
|
| Calgranulin A | 1 | 2018 | 81 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 319 | 0.140 |
Why?
|
| Cyclin A | 1 | 2017 | 60 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 3735 | 0.140 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 78 | 0.140 |
Why?
|
| Protein Transport | 2 | 2022 | 1963 | 0.140 |
Why?
|
| Cyclin D | 1 | 2017 | 72 | 0.140 |
Why?
|
| Mice, Nude | 2 | 2022 | 3635 | 0.140 |
Why?
|
| Weight Gain | 5 | 2015 | 2357 | 0.140 |
Why?
|
| Adipose Tissue | 9 | 2016 | 3335 | 0.140 |
Why?
|
| Harmine | 1 | 2016 | 11 | 0.140 |
Why?
|
| Immunohistochemistry | 5 | 2022 | 11138 | 0.140 |
Why?
|
| Adaptation, Physiological | 2 | 2019 | 1315 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 617 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 348 | 0.140 |
Why?
|
| Fathers | 1 | 2020 | 377 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2016 | 2434 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2020 | 2067 | 0.140 |
Why?
|
| Mutation | 11 | 2023 | 30243 | 0.140 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 79 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 2008 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2012 | 2884 | 0.130 |
Why?
|
| Tubercidin | 1 | 2016 | 15 | 0.130 |
Why?
|
| Middle Aged | 21 | 2021 | 223418 | 0.130 |
Why?
|
| Transplantation Chimera | 1 | 2019 | 594 | 0.130 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 1021 | 0.130 |
Why?
|
| Organ Specificity | 4 | 2017 | 1972 | 0.130 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2016 | 50 | 0.130 |
Why?
|
| Tryptamines | 1 | 2016 | 93 | 0.130 |
Why?
|
| Adamantane | 1 | 2017 | 148 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2020 | 366 | 0.130 |
Why?
|
| Centromere | 1 | 2017 | 215 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2020 | 3169 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2006 | 863 | 0.130 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1995 | 139 | 0.130 |
Why?
|
| Osteoprotegerin | 1 | 2016 | 179 | 0.130 |
Why?
|
| Adipogenesis | 2 | 2008 | 370 | 0.130 |
Why?
|
| Zinc | 1 | 2020 | 677 | 0.130 |
Why?
|
| Interleukin-6 | 3 | 2016 | 3234 | 0.130 |
Why?
|
| Smad3 Protein | 1 | 2016 | 166 | 0.130 |
Why?
|
| Nutrition Disorders | 2 | 1993 | 204 | 0.120 |
Why?
|
| Hemarthrosis | 1 | 2015 | 39 | 0.120 |
Why?
|
| Genes, cdc | 1 | 2015 | 114 | 0.120 |
Why?
|
| Pyrrolidines | 1 | 2017 | 341 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 250 | 0.120 |
Why?
|
| Protein Folding | 3 | 2014 | 875 | 0.120 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1995 | 179 | 0.120 |
Why?
|
| Receptors, Glucagon | 2 | 2012 | 90 | 0.120 |
Why?
|
| Body Weight | 7 | 2013 | 4630 | 0.120 |
Why?
|
| Drug Discovery | 2 | 2022 | 1062 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2019 | 1083 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2010 | 501 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2016 | 306 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 5 | 2018 | 5442 | 0.120 |
Why?
|
| Antigens, CD34 | 1 | 2017 | 656 | 0.120 |
Why?
|
| Amyloid | 2 | 1996 | 852 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2018 | 342 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2014 | 51 | 0.120 |
Why?
|
| Transgenes | 4 | 2009 | 1015 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 584 | 0.120 |
Why?
|
| Proteins | 2 | 2020 | 6008 | 0.120 |
Why?
|
| Adiposity | 2 | 2017 | 1888 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2014 | 97 | 0.110 |
Why?
|
| Blood Coagulation Disorders | 1 | 2017 | 350 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 975 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2020 | 866 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2910 | 0.110 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 462 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 163 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 136 | 0.110 |
Why?
|
| Receptors, IgE | 1 | 2015 | 375 | 0.110 |
Why?
|
| Europe | 2 | 2018 | 3439 | 0.110 |
Why?
|
| Fasting | 6 | 2016 | 1608 | 0.110 |
Why?
|
| Palmitic Acid | 1 | 2014 | 149 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2012 | 203 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 9 | 2010 | 6135 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 1009 | 0.110 |
Why?
|
| Amino Acid Sequence | 6 | 2017 | 13452 | 0.110 |
Why?
|
| Nucleosides | 1 | 2013 | 131 | 0.110 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2819 | 0.110 |
Why?
|
| Culture Media | 1 | 2015 | 899 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1036 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 532 | 0.110 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 501 | 0.110 |
Why?
|
| Sterol Esterase | 1 | 2013 | 39 | 0.110 |
Why?
|
| S-Nitrosothiols | 1 | 2012 | 35 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2013 | 63 | 0.110 |
Why?
|
| Indoles | 3 | 2014 | 1834 | 0.110 |
Why?
|
| Serum | 1 | 2014 | 208 | 0.100 |
Why?
|
| Blotting, Northern | 4 | 2000 | 1553 | 0.100 |
Why?
|
| Gene Order | 1 | 2013 | 169 | 0.100 |
Why?
|
| Sulfonamides | 2 | 2013 | 1988 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 661 | 0.100 |
Why?
|
| Radioimmunoassay | 3 | 2000 | 862 | 0.100 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2011 | 394 | 0.100 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2017 | 317 | 0.100 |
Why?
|
| Adolescent | 14 | 2018 | 89168 | 0.100 |
Why?
|
| Oximes | 1 | 2014 | 304 | 0.100 |
Why?
|
| Mass Spectrometry | 5 | 2017 | 2204 | 0.100 |
Why?
|
| Rats | 13 | 2014 | 23839 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 712 | 0.100 |
Why?
|
| Heterozygote | 3 | 2011 | 2792 | 0.100 |
Why?
|
| Transplants | 1 | 2014 | 208 | 0.100 |
Why?
|
| Osteocytes | 1 | 2014 | 193 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 635 | 0.100 |
Why?
|
| Oxidation-Reduction | 4 | 2013 | 2232 | 0.100 |
Why?
|
| Genotype | 5 | 2014 | 13047 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2016 | 4138 | 0.100 |
Why?
|
| Histones | 2 | 2020 | 2595 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2011 | 12 | 0.100 |
Why?
|
| RNA Interference | 5 | 2015 | 2832 | 0.100 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 875 | 0.100 |
Why?
|
| Macrophages | 2 | 2018 | 5797 | 0.100 |
Why?
|
| Nitriles | 1 | 2017 | 984 | 0.100 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2011 | 45 | 0.100 |
Why?
|
| Spleen | 2 | 2016 | 2298 | 0.100 |
Why?
|
| Ritonavir | 1 | 2013 | 330 | 0.100 |
Why?
|
| Hemostasis | 1 | 2014 | 470 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2039 | 0.100 |
Why?
|
| Body Fluids | 1 | 2013 | 322 | 0.100 |
Why?
|
| Mice, Inbred DBA | 3 | 2004 | 624 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1999 | 1803 | 0.100 |
Why?
|
| Cytosol | 2 | 2017 | 889 | 0.100 |
Why?
|
| Young Adult | 12 | 2022 | 60045 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 268 | 0.090 |
Why?
|
| Chemokines | 1 | 2016 | 963 | 0.090 |
Why?
|
| Bone Marrow | 2 | 2018 | 2929 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 440 | 0.090 |
Why?
|
| Glycolysis | 1 | 2015 | 838 | 0.090 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 892 | 0.090 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 825 | 0.090 |
Why?
|
| Oxidative Stress | 4 | 2019 | 3145 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 757 | 0.090 |
Why?
|
| Cyclic AMP | 4 | 2018 | 1468 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 287 | 0.090 |
Why?
|
| Karyotyping | 1 | 2013 | 1173 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 840 | 0.090 |
Why?
|
| Rats, Wistar | 5 | 2014 | 1891 | 0.090 |
Why?
|
| Crosses, Genetic | 4 | 2006 | 753 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2010 | 484 | 0.090 |
Why?
|
| von Willebrand Factor | 1 | 2014 | 679 | 0.090 |
Why?
|
| S Phase | 1 | 2011 | 425 | 0.090 |
Why?
|
| Acetylglucosamine | 1 | 2012 | 189 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2017 | 2674 | 0.090 |
Why?
|
| G1 Phase | 1 | 2011 | 404 | 0.090 |
Why?
|
| Pedigree | 3 | 2013 | 4545 | 0.090 |
Why?
|
| Interleukins | 2 | 2013 | 792 | 0.090 |
Why?
|
| Physical Exertion | 1 | 1993 | 669 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 4780 | 0.090 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 753 | 0.090 |
Why?
|
| Aged | 11 | 2020 | 171520 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 17647 | 0.090 |
Why?
|
| Oligopeptides | 1 | 1995 | 1193 | 0.090 |
Why?
|
| Protein Binding | 3 | 2019 | 9376 | 0.090 |
Why?
|
| Osteoclasts | 1 | 2014 | 712 | 0.090 |
Why?
|
| Enzyme Inhibitors | 4 | 2016 | 3734 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 873 | 0.080 |
Why?
|
| Neuropeptides | 1 | 1995 | 950 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2018 | 2944 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2012 | 7599 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 582 | 0.080 |
Why?
|
| Cannabinoids | 1 | 2012 | 173 | 0.080 |
Why?
|
| Cricetinae | 3 | 2000 | 2423 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.080 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 2415 | 0.080 |
Why?
|
| Mothers | 1 | 2020 | 2210 | 0.080 |
Why?
|
| Pancreatectomy | 1 | 2013 | 824 | 0.080 |
Why?
|
| Zebrafish | 2 | 2022 | 3038 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2016 | 1087 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2696 | 0.080 |
Why?
|
| Chromatin | 1 | 2020 | 2969 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2014 | 542 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2023 | 3442 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2018 | 2942 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 2489 | 0.080 |
Why?
|
| Duodenum | 1 | 2012 | 495 | 0.080 |
Why?
|
| Infant, Newborn | 3 | 2022 | 26395 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3665 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 525 | 0.080 |
Why?
|
| Quality of Life | 2 | 2023 | 13497 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2009 | 209 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2015 | 1322 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2014 | 1009 | 0.080 |
Why?
|
| Osteoblasts | 1 | 2014 | 1154 | 0.080 |
Why?
|
| Stimulation, Chemical | 2 | 2000 | 306 | 0.080 |
Why?
|
| Immunoprecipitation | 3 | 2019 | 876 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 6 | 2008 | 5803 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1563 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2013 | 2865 | 0.070 |
Why?
|
| Cell Size | 2 | 2007 | 626 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2017 | 1671 | 0.070 |
Why?
|
| Cyclin D1 | 1 | 2010 | 454 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2010 | 562 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1602 | 0.070 |
Why?
|
| Somatostatin | 1 | 2010 | 448 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 673 | 0.070 |
Why?
|
| Glycerol Kinase | 1 | 2007 | 17 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2012 | 1207 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2666 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2007 | 103 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1885 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 325 | 0.070 |
Why?
|
| Animal Feed | 1 | 2007 | 110 | 0.070 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2008 | 338 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2019 | 5103 | 0.070 |
Why?
|
| TRPV Cation Channels | 1 | 2008 | 244 | 0.070 |
Why?
|
| Lysine | 1 | 2011 | 989 | 0.070 |
Why?
|
| Fats | 1 | 2007 | 99 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2009 | 539 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 15965 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 4781 | 0.070 |
Why?
|
| Family Health | 2 | 2009 | 1256 | 0.070 |
Why?
|
| Cell Death | 1 | 2012 | 1684 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 561 | 0.070 |
Why?
|
| Nervous System | 1 | 2010 | 547 | 0.070 |
Why?
|
| Glucose Clamp Technique | 3 | 2015 | 263 | 0.070 |
Why?
|
| Islet Amyloid Polypeptide | 2 | 1996 | 41 | 0.070 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2006 | 72 | 0.070 |
Why?
|
| Aquaporins | 1 | 2007 | 179 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2009 | 856 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2020 | 4421 | 0.070 |
Why?
|
| Plasma | 1 | 2009 | 588 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 621 | 0.070 |
Why?
|
| Glycerol | 1 | 2007 | 275 | 0.070 |
Why?
|
| Research | 1 | 2014 | 1984 | 0.070 |
Why?
|
| Immunoassay | 1 | 2009 | 746 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 1461 | 0.060 |
Why?
|
| Serine | 1 | 2009 | 831 | 0.060 |
Why?
|
| Norepinephrine | 3 | 1998 | 900 | 0.060 |
Why?
|
| Kinetics | 4 | 2013 | 6348 | 0.060 |
Why?
|
| Software | 1 | 2019 | 4463 | 0.060 |
Why?
|
| Lipodystrophy | 2 | 2017 | 145 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2009 | 3594 | 0.060 |
Why?
|
| Catalysis | 2 | 2020 | 769 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1625 | 0.060 |
Why?
|
| Homozygote | 1 | 2010 | 1779 | 0.060 |
Why?
|
| Glyceraldehyde | 1 | 2004 | 5 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2008 | 624 | 0.060 |
Why?
|
| Transfection | 5 | 2018 | 5767 | 0.060 |
Why?
|
| DNA | 2 | 2017 | 7213 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2004 | 27 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2004 | 10 | 0.060 |
Why?
|
| Child | 5 | 2018 | 80863 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 12774 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2011 | 1599 | 0.060 |
Why?
|
| 5' Untranslated Regions | 2 | 2018 | 255 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2004 | 64 | 0.060 |
Why?
|
| Integrases | 2 | 2014 | 520 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2017 | 3586 | 0.060 |
Why?
|
| Sex Factors | 1 | 2018 | 10647 | 0.060 |
Why?
|
| Infusions, Intravenous | 5 | 2015 | 2228 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 2258 | 0.060 |
Why?
|
| Disease Progression | 2 | 2019 | 13655 | 0.060 |
Why?
|
| Oscillometry | 1 | 2004 | 150 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 18478 | 0.060 |
Why?
|
| Half-Life | 2 | 2015 | 650 | 0.060 |
Why?
|
| Fructokinases | 1 | 2023 | 6 | 0.060 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2004 | 132 | 0.060 |
Why?
|
| NIH 3T3 Cells | 3 | 2011 | 669 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2004 | 127 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2013 | 6527 | 0.050 |
Why?
|
| Diabetes Mellitus, Lipoatrophic | 1 | 2002 | 9 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 388 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 659 | 0.050 |
Why?
|
| Perfusion | 2 | 2000 | 1402 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2005 | 222 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2017 | 8081 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1337 | 0.050 |
Why?
|
| Drug Therapy, Combination | 4 | 2014 | 6320 | 0.050 |
Why?
|
| Drug Administration Schedule | 4 | 2015 | 4861 | 0.050 |
Why?
|
| Isoindoles | 2 | 2013 | 37 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2004 | 174 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2013 | 2102 | 0.050 |
Why?
|
| Pyruvates | 1 | 2022 | 83 | 0.050 |
Why?
|
| Biological Transport | 2 | 2022 | 2089 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2005 | 2882 | 0.050 |
Why?
|
| Inflammation | 3 | 2018 | 10865 | 0.050 |
Why?
|
| Pyridines | 1 | 2014 | 2888 | 0.050 |
Why?
|
| Age of Onset | 1 | 2009 | 3342 | 0.050 |
Why?
|
| Amylases | 1 | 2022 | 171 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2018 | 65409 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2011 | 2377 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2014 | 3050 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 2 | 2013 | 363 | 0.050 |
Why?
|
| Imidazoles | 2 | 2020 | 1174 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2023 | 216 | 0.050 |
Why?
|
| Cyclopropanes | 2 | 2013 | 437 | 0.050 |
Why?
|
| Fructose | 1 | 2023 | 285 | 0.050 |
Why?
|
| Diet | 3 | 2022 | 8098 | 0.050 |
Why?
|
| Hypothalamus | 2 | 2010 | 1004 | 0.050 |
Why?
|
| Proline | 2 | 2013 | 456 | 0.050 |
Why?
|
| Lactams, Macrocyclic | 2 | 2013 | 318 | 0.050 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2022 | 147 | 0.050 |
Why?
|
| Biopsy | 1 | 2013 | 6816 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 674 | 0.040 |
Why?
|
| Tolbutamide | 1 | 2000 | 23 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 2003 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 5808 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3048 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8051 | 0.040 |
Why?
|
| Lymphokines | 1 | 2003 | 927 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2011 | 1977 | 0.040 |
Why?
|
| Aging | 4 | 2008 | 8761 | 0.040 |
Why?
|
| Weaning | 1 | 2020 | 103 | 0.040 |
Why?
|
| Australia | 2 | 2015 | 1264 | 0.040 |
Why?
|
| Viral Load | 3 | 2014 | 3399 | 0.040 |
Why?
|
| Parabiosis | 1 | 2019 | 65 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2018 | 14 | 0.040 |
Why?
|
| United States | 4 | 2018 | 73121 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 369 | 0.040 |
Why?
|
| Skin | 1 | 2013 | 4520 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 24311 | 0.040 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 1998 | 47 | 0.040 |
Why?
|
| Vancomycin | 1 | 2022 | 506 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2013 | 4294 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 16029 | 0.040 |
Why?
|
| Interferons | 2 | 2013 | 714 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2003 | 1438 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 2 | 2015 | 242 | 0.040 |
Why?
|
| Radioligand Assay | 2 | 1995 | 366 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2018 | 69 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2003 | 10784 | 0.040 |
Why?
|
| Drug Resistance, Viral | 2 | 2013 | 869 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2018 | 126 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 61 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 17149 | 0.040 |
Why?
|
| Genetic Vectors | 4 | 2010 | 3417 | 0.040 |
Why?
|
| Tyrosine | 1 | 2022 | 1428 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 18048 | 0.040 |
Why?
|
| Palmitates | 1 | 2018 | 70 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 4567 | 0.040 |
Why?
|
| Thiamine | 1 | 2019 | 160 | 0.040 |
Why?
|
| Protein Multimerization | 2 | 2013 | 980 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2012 | 1992 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2006 | 3520 | 0.040 |
Why?
|
| Galanin | 1 | 1997 | 42 | 0.040 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2017 | 87 | 0.040 |
Why?
|
| Protein Precursors | 3 | 2012 | 1133 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3708 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2003 | 864 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2014 | 598 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1997 | 204 | 0.030 |
Why?
|
| Estrogens | 2 | 2014 | 1531 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2011 | 1585 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 59680 | 0.030 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 2016 | 16 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2009 | 3202 | 0.030 |
Why?
|
| Adenoviridae | 3 | 2008 | 1098 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1905 | 0.030 |
Why?
|
| Binding Sites | 2 | 2018 | 6030 | 0.030 |
Why?
|
| HIV-1 | 1 | 2014 | 6966 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1706 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 515 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2018 | 420 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1369 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 2016 | 175 | 0.030 |
Why?
|
| Dioxoles | 1 | 2016 | 96 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 2015 | 69 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2014 | 4041 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2126 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3431 | 0.030 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 1995 | 66 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1995 | 175 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2020 | 1765 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 2643 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3794 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 2016 | 148 | 0.030 |
Why?
|
| Creatinine | 2 | 2014 | 1915 | 0.030 |
Why?
|
| Alleles | 2 | 2014 | 6890 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 1995 | 157 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 564 | 0.030 |
Why?
|
| Muscles | 2 | 2006 | 1582 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2139 | 0.030 |
Why?
|
| Body Temperature Regulation | 3 | 1992 | 292 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.030 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 344 | 0.030 |
Why?
|
| Basal Metabolism | 2 | 1993 | 163 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 130 | 0.030 |
Why?
|
| Pancrelipase | 1 | 2014 | 7 | 0.030 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1995 | 108 | 0.030 |
Why?
|
| Hemostatics | 1 | 2017 | 246 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2014 | 12450 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2014 | 50 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2017 | 289 | 0.030 |
Why?
|
| Pyrazines | 1 | 2020 | 1206 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2003 | 2326 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3816 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2014 | 242 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 2014 | 116 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2015 | 42623 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 74915 | 0.030 |
Why?
|
| Fatty Acids | 2 | 2015 | 1818 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2014 | 161 | 0.030 |
Why?
|
| S-Nitrosoglutathione | 1 | 2012 | 23 | 0.030 |
Why?
|
| Drug Design | 1 | 2018 | 1050 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 469 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2014 | 277 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2013 | 220 | 0.030 |
Why?
|
| Time Factors | 5 | 2018 | 40271 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 320 | 0.030 |
Why?
|
| Octoxynol | 1 | 2012 | 76 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 1112 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6242 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 284 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1969 | 0.030 |
Why?
|
| France | 1 | 2014 | 497 | 0.030 |
Why?
|
| Pakistan | 1 | 2013 | 298 | 0.030 |
Why?
|
| Carbamates | 1 | 2014 | 192 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 1909 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 2014 | 1086 | 0.020 |
Why?
|
| Hexosamines | 1 | 2012 | 38 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2017 | 968 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2014 | 321 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2015 | 1650 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 36497 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 808 | 0.020 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 516 | 0.020 |
Why?
|
| bcl-Associated Death Protein | 1 | 2012 | 102 | 0.020 |
Why?
|
| Peptide Fragments | 3 | 2003 | 5152 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 394 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2012 | 240 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 3073 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 631 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2018 | 2363 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2014 | 732 | 0.020 |
Why?
|
| Reticulocytes | 1 | 2012 | 289 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 681 | 0.020 |
Why?
|
| Ligands | 1 | 2018 | 3281 | 0.020 |
Why?
|
| North America | 1 | 2015 | 1292 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2011 | 34 | 0.020 |
Why?
|
| New Zealand | 1 | 2012 | 360 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 773 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 605 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2013 | 389 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2011 | 229 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2010 | 80 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2014 | 865 | 0.020 |
Why?
|
| Quinolones | 1 | 2014 | 382 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2010 | 100 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2017 | 807 | 0.020 |
Why?
|
| Estrus | 1 | 2010 | 70 | 0.020 |
Why?
|
| Benzamides | 1 | 2016 | 1381 | 0.020 |
Why?
|
| India | 1 | 2017 | 2323 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1126 | 0.020 |
Why?
|
| Body Composition | 2 | 2005 | 2455 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2023 | 3586 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 1744 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 7064 | 0.020 |
Why?
|
| Progesterone | 1 | 2014 | 750 | 0.020 |
Why?
|
| South Africa | 1 | 2015 | 1870 | 0.020 |
Why?
|
| Autoantibodies | 2 | 2008 | 2131 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6241 | 0.020 |
Why?
|
| Menopause | 1 | 2017 | 1651 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2010 | 400 | 0.020 |
Why?
|
| Species Specificity | 2 | 2004 | 2422 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 1510 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2014 | 54914 | 0.020 |
Why?
|
| China | 1 | 2015 | 2398 | 0.020 |
Why?
|
| Cation Exchange Resins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 1680 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 706 | 0.020 |
Why?
|
| RNA Polymerase III | 1 | 2008 | 59 | 0.020 |
Why?
|
| Histone Demethylases | 1 | 2011 | 322 | 0.020 |
Why?
|
| Wakefulness | 1 | 2015 | 1280 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2010 | 268 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2014 | 964 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 110 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2008 | 294 | 0.020 |
Why?
|
| Adenine | 1 | 2014 | 993 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 2173 | 0.020 |
Why?
|
| Cysteine | 1 | 2012 | 895 | 0.020 |
Why?
|
| Lysosomes | 1 | 2013 | 934 | 0.020 |
Why?
|
| Anemia | 1 | 2017 | 1521 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2143 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 2596 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 712 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 2079 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 2393 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 2103 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6091 | 0.020 |
Why?
|
| HIV Infections | 1 | 2014 | 17564 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2007 | 207 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 1322 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 1688 | 0.020 |
Why?
|
| Thiazoles | 1 | 2014 | 1541 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 1837 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2006 | 131 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 870 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 241 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2072 | 0.020 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 37 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 856 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 956 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 1494 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2006 | 186 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 682 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2006 | 177 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9687 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 2226 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2010 | 752 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 2269 | 0.010 |
Why?
|
| Heart Rate | 2 | 2014 | 4218 | 0.010 |
Why?
|
| Cell Membrane | 2 | 2008 | 3664 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1543 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2012 | 3973 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4362 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1997 | 4948 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1309 | 0.010 |
Why?
|
| Energy Intake | 1 | 1992 | 2141 | 0.010 |
Why?
|
| Androstadienes | 1 | 2006 | 348 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2640 | 0.010 |
Why?
|
| Brain | 3 | 2014 | 27438 | 0.010 |
Why?
|
| Virus Replication | 1 | 2012 | 2459 | 0.010 |
Why?
|
| Survival Rate | 2 | 2011 | 12875 | 0.010 |
Why?
|
| Chromans | 1 | 2003 | 117 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8730 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 666 | 0.010 |
Why?
|
| Prednisone | 1 | 2007 | 1568 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 1152 | 0.010 |
Why?
|
| Thinness | 1 | 2006 | 483 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 447 | 0.010 |
Why?
|
| Receptors, Somatomedin | 1 | 2002 | 57 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13324 | 0.010 |
Why?
|
| Longevity | 1 | 2010 | 1077 | 0.010 |
Why?
|
| Caloric Restriction | 1 | 2005 | 300 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 816 | 0.010 |
Why?
|
| Family | 1 | 2013 | 3208 | 0.010 |
Why?
|
| Rabbits | 1 | 2008 | 4786 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2008 | 1503 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 463 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8635 | 0.010 |
Why?
|
| Piperidines | 1 | 2011 | 1664 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 22386 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2002 | 102 | 0.010 |
Why?
|
| Subrenal Capsule Assay | 1 | 2001 | 27 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2150 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 750 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3278 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2006 | 843 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1993 | 9382 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2014 | 6278 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 2002 | 214 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4120 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 2000 | 91 | 0.010 |
Why?
|
| Bone Density | 1 | 2014 | 3561 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2014 | 6410 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 2024 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
| Glycogen | 1 | 2000 | 252 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 3090 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2000 | 333 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2000 | 169 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 2056 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1998 | 398 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41797 | 0.010 |
Why?
|
| Peptide YY | 1 | 1998 | 135 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2007 | 2170 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 1726 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2001 | 692 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 2392 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12096 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 1683 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1775 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2565 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2011 | 13030 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3437 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26351 | 0.010 |
Why?
|
| Imidazoline Receptors | 1 | 1995 | 13 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 1144 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8559 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1998 | 1035 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 2465 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14766 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3122 | 0.010 |
Why?
|
| Eating | 1 | 2001 | 1538 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 4941 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12428 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 13026 | 0.010 |
Why?
|
| Calorimetry | 1 | 1992 | 132 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10273 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5709 | 0.010 |
Why?
|
| Swine | 1 | 1998 | 5996 | 0.000 |
Why?
|
| Research Design | 1 | 2002 | 6217 | 0.000 |
Why?
|
| Oxygen | 1 | 1998 | 4269 | 0.000 |
Why?
|
| Rest | 1 | 1989 | 952 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1989 | 8538 | 0.000 |
Why?
|